Towa Pharmaceutical Co., Ltd. (4553)
Market Closed
5 Oct, 06:25 AM
¥
3,500. 00
+5
+0.1431%
¥
160.73B Market Cap
- P/E Ratio
80% Div Yield
64,500 Volume
- Eps
¥ 3,495
Previous Close Want to track 4553 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Towa Pharmaceutical Co., Ltd. (4553) Statistics
Valuation metrics
Market Cap 160.73B
Enterprise value 365.9B
Trailing P/E (ttm) 21.55
Forward P/E 13.11
PEG ratio -0.45
Price/Sales (ttm) 0.64
Price/Book (mrq) 0.98
Enterprise Value/Revenue 1.31
Enterprise Value/EBITDA 9.13
Overview
Shares outstanding 49.23M
Float 23.01M
Shares short -
% Held by insiders 0.48%
% Held by institutions 0.2%
Average volume (10 days) 92.1K
Average volume (90 days) 111.87K
Price summary
52-Week low 2,764
52-Week high 4,490
Beta -0.3
50-Day moving average 3,689.46
200-Day moving average 3,902
Dividends and splits
Forward annual dividend rate 80
Forward annual dividend yield 0.0207%
Trailing annual dividend rate 80
Trailing annual dividend yield 0.0221%
5-Year annual dividend yield 2.29%
Payout ratio 0.48
Dividend Date 29 Sep 2026
Ex-Dividend Date 29 Sep 2026
Last split factor 3:1
Last split Date 27 Mar 2019
Financials
Fiscal year
Fiscal year ends 31 Mar 2026
Most recent quarter (mrq) 30 Jun 2025
Profitability
Profit margin 0.03%
Operating margin 0.09%
Operational effectiveness
Return on assets 0.02%
Return on equity 0.05%
Income Statement
Revenue (ttm) 273.71B
Revenue per share (ttm) 5,686.62
Quarterly revenue growth (yoy) 0.06%
Gross profit (ttm) 99.1B
EBITDA 46.62B
Net income to common (ttm) 5.25B
Diluted EPS (ttm) 167.95
Quarterly earnings growth (yoy) 0.1%
Balance Sheet
Total cash (mrq) 45.31B
Total cash per share (mrq) 857.82
Total debt (mrq) 228.95B
Total Debt/Equity (mrq) 1.26
Current ratio (mrq) 2.82%
Book value per share (mrq) 3,706.81
Cash Flow
Cash flow statement 30.43B
Levered free cash flow (LFCF) -2.86B
2026 © Marketlog. All Rights Reserved.
